SEC Form 4 · accession 0001209191-18-002816
IMMUNE DESIGN CORP. · IMDZ
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Lewis W Coleman
Director
Period of report
Jan 4, 2018
Accepted (ET)
Jan 8, 2018 · 8:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001437786
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $4.05 | Jan 4, 2018 | A | 12,500 | A | — | Jan 4, 2028 | Common Stock | 12,500 | 12,500 | D |
Explanation of responses
- F1All shares underlying the option will vest on January 4, 2019.